HOA with Arrotex(Australias Largest Generic OTC Supplier), to...

HOA with Arrotex(Australias Largest Generic OTC Supplier), to accelerate NanoCB access for Pharmacy; Dr Sean Hall, CEO of Medlab states, “This is a major milestone for both the Australian market and the budding partnership between Medlab and Arrotex. Unlike many CBD producers, Medlab can deliver to the pharmaceutical standards required for TGA approval and this partnership will now enable direct application into clinical practice through Arrotex’s extensive network. There is a clear alignment within both companies to deliver a superior, approved CBD product to Australian patients.”

- Development positions NanoCBD™ for pharmacist only medicines schedule (S3)
- Medlab’s pharmaceutical standards of safety, stability and dose specifics primed for fast application to TGA registration
- NanoCBD™ significantly differentiated by Medlab’s proprietary delivery platform, NanoCelle®
http://wcsecure.weblink.com.au/pdf/MDC/02342965.pdf